SciELO - Scientific Electronic Library Online

 
vol.32 issue1Strategies to improve knowledge, attitude, and practice in COVID-19 prevention and control measures: a systematic reviewNeuroleptic malignant syndrome secondary to quetiapine author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la OFIL

On-line version ISSN 1699-714XPrint version ISSN 1131-9429

Abstract

PROY-VEGA, B; GOMEZ-LLUCH, MT; ALANON-PARDO, MM  and  NOTARIO-DONGIL, C. Refractory oral aftas in treatment with adalimumab and apremilast in patient with Behçet syndrome. A case report. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.1, pp.99-100.  Epub Nov 21, 2022. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x20220001000018.

Behçet's disease is a multisystemic inflammatory disorder that manifests itself in a variety of ways at the cutaneous level, especially in the form of oral thrush, very often very refractory. Treatments that are useful in the symptomatology of this pathology are not very specific and not very effective; sometimes it is necessary to resort to systemic treatments, such as biologi-cal ones: among them, anti-TNFα.

We present the case of a patient diagnosed with Behçet's disease, with severe oral aphthae, very recurrent and refractory to multiple treatments. Currently, the patient has reached clinical remission in combined treatment of adalimumab and apremilast.

Keywords : Apremilast; adalimumab; Behçet; oral thrush; refractary.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )